Aethlon announces reverse stock split

San diego , oct. 4, 2023 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that its board of directors has approved a 1-for-10 reverse stock split of the company's common stock, effective at 5:00 p.m. et on october 4, 2023.

AEMD Ratings Summary

AEMD Quant Ranking